Clinical Trial: Hypertension Treatment in Nigeria: Hypertension Diabetes Integration Study- Formative Aim 3

U.S., May 16 -- ClinicalTrials.gov registry received information related to the study (NCT07589387) titled 'Hypertension Treatment in Nigeria: Hypertension Diabetes Integration Study- Formative Aim 3' on April 29.

Brief Summary: The purpose of the second phase of the Hypertension Treatment in Nigeria (HTN 2.0) Program is to build upon the success of the first phase of the HTN Program (2020-2023), which implemented the WHO HEARTS package across 60 primary healthcare centers (PHCs) in the Federal Capital Territory (FCT). This program demonstrated significant improvements in hypertension treatment and control. The focus of aim 3 will be evaluating diabetes management through the implementation of the HEARTS-D bundle in 10 PHCs across the FCT ...